THE-PENINSULA-HOTELS
9.2.2021 07:02:26 CET | Business Wire | Press release
The Peninsula Hotels, whose international hospitality brand has epitomised glamour and luxury for nearly a century, today announced the winner of its sixth annual classic car showcase, The Peninsula Classics 2020 Best of the Best Award. The winning car, the 1954 Ferrari 750 Monza, coachwork by Scaglietti , has achieved distinction both for its impressive racing history and its exacting restoration. It became eligible as a Best of the Best Award contender after winning Best of Show at the 2020 Palm Beach Cavallino Classic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005295/en/
The Best of the Best Award was co-founded in 2015 by The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited (owner and operator of The Peninsula Hotels), along with William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. The Award celebrates the fine engineering and design of classic cars built by internationally renowned manufacturers, selected from an exceptional short list of winners from the most exclusive concours. This year’s award has a contracted list of nominees due to cancellation or postponement of partner concours in 2020 as a result of the COVID-19.
The 1954 Ferrari 750 Monza was chosen from a selection of four nominees crafted by automakers from Italy, Germany, and the United States, including a 1969 Porsche 917 KH Coupé, coachwork by the Factory, 2020 Best of Show, Concours of Elegance Hampton Court Palace, 1931 Alfa Romeo 8C 2300 Monza Spider, coachwork by Zagato, 2020 Best of Show, Salon Privé and a 1929 Duesenberg Model J Town Limousine, coachwork by Murphy, 2020 Best of Show, Amelia Island Concours d’Elegance.
The winner was selected by The Best of the Best Award’s esteemed panel of judges, including, amongst others, designers Gordon Murray (former Formula 1 designer for Brabham and McLaren) and Anne Asensio (Vice President of Design Experience at Dassault Systèmes), and prominent classic car collectors Laurence Graff and Jay Leno.
“It was a difficult task for our judges to select a winner this year. Our judging procedures had to be carried out remotely and unfortunately the main awards event had to be cancelled, with social distancing measures and safety our top priority,” said The Hon. Sir Michael Kadoorie. “With such a prestigious collection of nominees, choosing one winner was especially challenging. However, it is always a great pleasure to spotlight the remarkable achievements of the automotive industry, and to create a small spark of joy in the current challenging times. These classic vehicles are an enduring testament to human artistry and ingenuity.”
The winning 750 Monza made its original debut with a 2-litre motor at the Inaugural Grand Prix of the Imola Autodrome in June of 1954. After driver Umberto Maglioli secured first place for Scuderia Ferrari with the car, it was subsequently fitted with a 3-litre engine and went on to compete in several other major races that year, including the Monsanto Grand Prix (where it won), and Nassau Race Week – where it was driven by its original owner, Alfonso de Portago, and secured a 1st and two 2nd places.
The car’s next owner, Sterling Edwards, raced the 750 Monza over the next two years mainly in California, including the Pebble Beach Road Races (an event he founded) in 1955 and 1956 – garnering four 1st-place and two first-in-class wins in the car. After the tragic death of his friend Ernie McAfee prompted Edwards to stop racing altogether, he sold the car to his engineer Bob Whitmer, who replaced its engine with a Chevy V8 and continued to successfully race it through the early 1960s.
The car spent most of the ensuing 50 years disassembled, though its chassis, body, engine, and gearbox were all carefully preserved in a small San Francisco-area warehouse. In 2016, a complete restoration of the car was initiated under the direction of Bob Smith Coachworks, located in Gainesville, Texas, a process that took new owners Tom and Jill Peck of southern California over two years to complete.
The refurbishment was guided by several noted Ferrari historians: Marcel Massini of Switzerland, Alan Boe of Braselton, Georgia, David Seielstad of Hawaii, as well as past owners Sterling Edwards’ son Hammond and Bob Whitmer, both from northern California. The vintage certification team at Ferrari Classiche in Maranello, Italy, was also helpful in piecing together the early racing career of the car while campaigned by Ferrari. Bringing their combined wealth of knowledge to the project, these experts employed many of the vehicle’s preserved original documents and instruments, including the original owners’ manual, toolboxes, build sheets, and a treasure trove of original photographs of the car. Computer modelling of these photos was employed to repair flaws in the body from the car’s racing days, and 3-D printing technology was utilised to duplicate some parts that were irreparable. The vehicle’s livery was restored to that which it sported in its first Carrera Panamericana race in 1954.
Once fully restored, the 1954 Ferrari 750 Monza won the Enzo Ferrari Award at the 2019 Pebble Beach Concours d’Elegance and 2020 Best of Show at the Cavallino Classic, before being named winner of The Peninsula Classics 2020 Best of the Best Award.
“It is a true honour to be recognised by the venerable judges of The Peninsula Classics,” said Mr. Peck of his car’s latest success. “Like so many classic cars, this one has been both a labour of love and the product of dedicated teamwork. The Best of the Best Award is a crowning achievement for everyone involved.”
About The Peninsula Classics Best of the Best Award
Through a shared desire to celebrate the best of what defines the automotive world, The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited, launched The Peninsula Classics Best of the Best Award in 2015 with co-founders William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. Each founder shares a common passion and appreciation of fine motor cars, the preservation of their heritage and immaculate restoration projects. The award, sponsored by The Peninsula Hotels , brings together elite ‘Best of Show’ winners from nine of the renown concours circuits around the globe: Amelia Island Concours d’Elegance, Cavallino Classic, Chantilly Arts & Elegance Richard Mille, Concorso d’Eleganza Villa d’Este, Concours of Elegance Hampton Court Palace, Goodwood Cartier Style et Luxe Concours d’Elegance, Pebble Beach Concours d’Elegance, Salon Privé, and The Quail, A Motorsports Gathering.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210208005295/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
